{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:08:46Z","timestamp":1791756526926,"version":"4.3.4"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/fpc.0000000000000199","type":"journal-article","created":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T09:57:10Z","timestamp":1451642230000},"page":"126-132","source":"Crossref","is-referenced-by-count":12,"title":["The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid"],"prefix":"10.1097","volume":"26","author":[{"given":"Irene","family":"Villegas-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"de-Miguel-El\u00edzaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Carrasco-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Marras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Canteras-Jordana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Yedra-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Mart\u00ednez-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Tortosa-Conesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mart\u00edn-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210213","first-page":"181","article-title":"Bone health in people with epilepsy: is it impaired and what are the risk factors S","volume":"17","author":"Pack","year":"2008","journal-title":"eizure"},{"key":"R2-3-20210213","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.yebeh.2004.02.005","article-title":"Antiepileptic drugs and reduced bone mineral density.","volume":"5","author":"Ali","year":"2004","journal-title":"Epilepsy Behav"},{"key":"R3-3-20210213","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cmpb.2010.08.011","article-title":"EPILEPSIAE - a European epilepsy database.","volume":"106","author":"Ihle","year":"2012","journal-title":"Comput Methods Programs Biomed"},{"key":"R4-3-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2009.10.011","article-title":"Bone and calcium metabolism and antiepileptic drugs.","volume":"112","author":"Verrotti","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"R5-3-20210213","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ane.12118","article-title":"Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy.","volume":"128","author":"Beerhorst","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"R6-3-20210213","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/WNL.58.9.1348","article-title":"Effect of antiepileptic drugs on bone density in ambulatory patients.","volume":"58","author":"Farhat","year":"2002","journal-title":"Neurology"},{"key":"R7-3-20210213","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yebeh.2006.11.007","article-title":"A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.","volume":"10","author":"Kim","year":"2007","journal-title":"Epilepsy Behav"},{"key":"R8-3-20210213","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.57.3.445","article-title":". Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy.","volume":"57","author":"Sato","year":"2001","journal-title":"Neurology"},{"key":"R9-3-20210213","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.0013-9580.2004.18804.x","article-title":"Fracture risk associated with use of antiepileptic drugs.","volume":"45","author":"Vestergaard","year":"2004","journal-title":"Epilepsia"},{"key":"R10-3-20210213","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.eplepsyres.2013.06.020","article-title":". Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED) - a prospective multicenter study.","volume":"106","author":"Bauer","year":"2013","journal-title":"Epilepsy Res"},{"key":"R11-3-20210213","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eplepsyres.2012.09.002","article-title":"Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.","volume":"104","author":"Koo","year":"2013","journal-title":"Epilepsy Res"},{"key":"R12-3-20210213","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1528-1167.2007.01176.x","article-title":". Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.","volume":"48","author":"Nissen-Meyer","year":"2007","journal-title":"Epilepsia"},{"key":"R13-3-20210213","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.eplepsyres.2013.08.012","article-title":"The effect of levetiracetam on rat bone mass, structure and metabolism.","volume":"107","author":"Fekete","year":"2013","journal-title":"Epilepsy Res"},{"key":"R14-3-20210213","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.seizure.2012.04.002","article-title":"Bone mineral density in adult patients treated with various antiepileptic drugs.","volume":"21","author":"Beniczky","year":"2012","journal-title":"Seizure"},{"key":"R15-3-20210213","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5507\/bp.2014.006","article-title":". The effect of lacosamide on bone tissue in orchidectomised male albino Wistar rats.","volume":"159","author":"Simko","year":"2015","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"R16-3-20210213","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1468-1331.2010.03103.x","article-title":". BsmI vitamin D receptors polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy.","volume":"18","author":"Lambrinoudaki","year":"2011","journal-title":"Eur J Neurol"},{"key":"R17-3-20210213","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/epi.12049","article-title":". The association between BsmI polymorphism and bone mineral density in young patients with epilepsy who are taking phenytoin.","volume":"54","author":"Phabphal","year":"2013","journal-title":"Epilepsia"},{"key":"R18-3-20210213","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI10347","article-title":". A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality.","volume":"107","author":"Mann","year":"2001","journal-title":"J Clin Invest"},{"key":"R19-3-20210213","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":". Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009.","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"R20-3-20210213","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.det.2009.08.006","article-title":"Skin type classification systems old and new.","volume":"27","author":"Roberts","year":"2009","journal-title":"Dermatol Clin"},{"key":"R21-3-20210213","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199804093381502","article-title":". Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women.","volume":"338","author":"Uitterlinden","year":"1998","journal-title":"N Engl J Med"},{"key":"R22-3-20210213","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/1529-0131(199902)42:2<285::AID-ANR10>3.0.CO;2-3","article-title":"Association of polymorphism at the type I collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover.","volume":"42","author":"Keen","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R23-3-20210213","first-page":"133","article-title":". COL1A1 Sp1 variation and bone phenotypes in an Italian population.","volume":"10","author":"Marini","year":"2013","journal-title":"Clin Cases Miner Bone Metab"},{"key":"R24-3-20210213","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S8756-3282(03)00087-5","article-title":"Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture.","volume":"32","author":"Mann","year":"2003","journal-title":"Bone"},{"key":"R25-3-20210213","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00198-010-1364-5","article-title":"Polymorphisms in the 5 flank of COL1A1 gene and osteoporosis: meta-analysis of published studies.","volume":"22","author":"Jin","year":"2011","journal-title":"Osteoporos Int"},{"key":"R26-3-20210213","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1371\/journal.pmed.0030090","article-title":". Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study.","volume":"3","author":"Ralston","year":"2006","journal-title":"PLoS Med"},{"key":"R27-3-20210213","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bone.2006.02.053","article-title":"COL1A1 Sp1 polymorphism associates with bone density in early puberty.","volume":"39","author":"Suuriniemi","year":"2006","journal-title":"Bone"},{"key":"R28-3-20210213","doi-asserted-by":"crossref","first-page":"E729","DOI":"10.1210\/jc.2013-3766","article-title":". A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk.","volume":"99","author":"Torekov","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-3-20210213","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1210\/jc.2015-1176","article-title":". GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women.","volume":"100","author":"Iepsen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-3-20210213","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.eplepsyres.2008.03.008","article-title":"Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.","volume":"80","author":"Elwakkad","year":"2008","journal-title":"Epilepsy Res"},{"key":"R31-3-20210213","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1528-1167.2009.02516.x","article-title":". Adverse effects of valproate on bone: defining a model to investigate the pathophysiology.","volume":"51","author":"Senn","year":"2010","journal-title":"Epilepsia"},{"key":"R32-3-20210213","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/pr1005263","article-title":"Valproate and bone loss: iTRAQ proteomics show that valproate reduces collagens and osteonectin in SMA cells.","volume":"9","author":"Fuller","year":"2010","journal-title":"J Proteome Res"},{"key":"R33-3-20210213","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.eplepsyres.2013.06.011","article-title":"Valproate reduces collagen and osteonectin in cultured bone cells.","volume":"106","author":"Humphrey","year":"2013","journal-title":"Epilepsy Res"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:23:10Z","timestamp":1620951790000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201603000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000199","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}